InvestSMART

AFT Pharmaceuticals Limited (ASX: AFP) - Announcements

- Current share price for AFP : $3.540

ASX company news and announcements for AFT Pharmaceuticals Limited (AFP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All AFT Pharmaceuticals Limited (AFP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than AFT Pharmaceuticals Limited (AFP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for AFT Pharmaceuticals Limited (AFP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$371 FINANCIAL RESULTS FOR HALF YEAR ENDED 30 SEPTEMBER 2020 19 Nov 2020 7:31AM $5.100 $3.540 fallen by 30.59%
$371 FINANCIAL RESULTS FOR HALF YEAR ENDED 30 SEPTEMBER 2020 19 Nov 2020 7:31AM $5.100 $3.540 fallen by 30.59%
$371 FINANCIAL RESULTS FOR HALF YEAR ENDED 30 SEPTEMBER 2020 19 Nov 2020 7:31AM $5.100 $3.540 fallen by 30.59%
$371 FINANCIAL RESULTS FOR HALF YEAR ENDED 30 SEPTEMBER 2020 19 Nov 2020 7:31AM $5.100 $3.540 fallen by 30.59%
$371 AFP opening European office, signs new partners for MXG 18 Nov 2020 8:43AM $4.980 $3.540 fallen by 28.92%
$371 AFT welcomes US FDA Complete Response Letter 9 Nov 2020 7:33AM $4.520 $3.540 fallen by 21.68%
$371 AFP appoints Anita Baldauf as a director 4 Nov 2020 7:55AM $4.810 $3.540 fallen by 26.40%
$371 AFP and Setek sign supply agreement 4 Nov 2020 7:53AM $4.810 $3.540 fallen by 26.40%
$371 Maxigesic IV distribution deals signed in UK and Hong Kong 3 Nov 2020 8:20AM $4.680 $3.540 fallen by 24.36%
$371 RLG:Kiwi Health Flagship Store Launch in China-Tmall Global 22 Oct 2020 9:38AM $4.650 $3.540 fallen by 23.87%
$371 AFP to annouce FY20H1 Interim results on Nov 19 2020 14 Oct 2020 7:31AM $4.540 $3.540 fallen by 22.03%
$371 ASM results 8 Sep 2020 2:14PM $4.940 $3.540 fallen by 28.34%
$371 ASM Chair's address 8 Sep 2020 8:25AM $4.800 $3.540 fallen by 26.25%
$371 ASM Presentation 8 Sep 2020 8:23AM $4.800 $3.540 fallen by 26.25%
$371 AGM Virtual Meeting Guide 24 Aug 2020 7:36AM $4.500 $3.540 fallen by 21.33%
$371 Notice of Adjourned Annual Meeting of Shareholders 2020 24 Aug 2020 7:36AM $4.500 $3.540 fallen by 21.33%
$371 Arrangements for the Adjourned 2020 Annual Meeting 24 Aug 2020 7:35AM $4.500 $3.540 fallen by 21.33%
$371 Issue of ordinary shares 13 Aug 2020 1:19PM $4.270 $3.540 fallen by 17.10%
$371 Adjournment of 2020 Annual Meeting 12 Aug 2020 7:30AM $4.250 $3.540 fallen by 16.71%
$371 Disclosure of Directors and Senior Managers Relevant Interes 10 Aug 2020 3:05PM $4.240 $3.540 fallen by 16.51%
$371 Conversion of redeemable preference shares 7 Aug 2020 3:14PM $4.150 $3.540 fallen by 14.70%
$371 Maxigesic IV licensed in six new European nations 30 Jul 2020 8:40AM $3.950 $3.540 fallen by 10.38%
$371 New Zealand codeine restrictions set for November 29 Jul 2020 7:30AM $3.900 $3.540 fallen by 9.23%
$371 Notice of Annual General Meeting 15 Jul 2020 7:31AM $4.090 $3.540 fallen by 13.45%
$371 RLG: RLG and AFT Launch Online NZ Health Store in China 10 Jul 2020 9:59AM $3.800 $3.540 fallen by 6.84%

226 - 250 of 546 results

Page 10 of 22

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.